Human papillomavirus (HPV) infection is a very common sexually transmitted infection, which affects more than 80% of people (men and women) at the start of their sexual life, recalls a recent press release from the Academy of Medicine. In France, these viruses are responsible, each year, for more than 100,000 benign genital warts, more than 30,000 pre-cancerous lesions and more than 8,000 cancers of the genital, anal and oropharyngeal regions. The first anti-HPV vaccines were put on the market in 2007. They have been gradually expanded to include, since 2018, the 9 types of HPV causing benign tumors, pre-cancers and HPV-dependent cancers. In 2007, global health recommendations for HPV vaccination were only for girls aged 11-14. In France, in 2019, the vaccination recommendations were extended to boys of the same age group with 65% coverage by Health Insurance from January 1, 2021, recalls the Academy. In 2020, in Europe, vaccination coverage exceeded 50% in 20 countries and 75% in eleven countries including Portugal, Spain and the United Kingdom. In France (in 27th position), it only reached 28% (mainly among girls), 29% for a single dose at 15 years old and 24% for a complete two-dose vaccination schedule at 16 years old. The following year, after the recommendations were extended to boys, French vaccination coverage was 41% (45.8% for girls and 6% for boys), a level very far from the objectives set by the Strategy. sexual health and the Cancer Plan: 60% among adolescent girls aged 11 to 19 in 2023 and 80% by 2030 [5,6]. How can this insufficient vaccination coverage observed in France be explained? The Academy of Medicine puts forward several explanations: a ten-year strategy to fight against cancer (2021-2030) mainly focused on the prevention of cervical cancer, therefore limited to girls; a lack of political and strategic coordination on the part of the Regional Health Agencies (ARS). Actions to improve anti-HPV vaccination coverage are rare in France and poorly coordinated when they exist; a lack of confidence among some health professionals who give up trying to convince their patients. Various surveys show that 40% of doctors do not systematically recommend this vaccination, evoking an act “badly perceived” by the parents. In a communiquéthe National Academy of Medicine recalls that it has spoken out on several occasions on the need to implement a national anti-HPV vaccination program for adolescents of both sexes, emphasizing the effectiveness and good tolerance of the vaccines marketed.
Insufficient HPV vaccination | Seronet
Tour de France 2022: Jakobsen uses his first chance to win
Why does your dog tilt his head to the side?
'Sasina' wins the 8th edition of the world championship - 'Supak' wins the Jet Ski World Series in t...
A Game-Changer After Sex: Dramatic Decline in Syphilis and Chlamydia Cases
The lack of hospital staff "results in deaths", warns emergency physician Christophe Prudhomme
Platense and another second division team could be invited to the National League for next season
What is muscle memory? - In the news
Responding to the challenges posed by antimicrobial resistance